Related Experiment Video
Updated: Jul 7, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Recognizing thyrotoxicosis in a patient with bipolar mania: a case report
Catherine See-Ning Lee1, Burton Hutto
1Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA. cslee@unch.unc.edu
Annals of General Psychiatry
|February 21, 2008
Summary
Thyroid stimulating hormone testing is crucial for patients with mania symptoms to rule out thyroid conditions like hyperthyroidism. Physicians should consider hyperthyroidism in bipolar mania patients unresponsive to standard treatments.
Area of Science:
- Endocrinology
- Psychiatry
- Neuroscience
Background:
- Thyroid stimulating hormone (TSH) levels are routinely checked in patients with mania symptoms to exclude medical conditions like hyperthyroidism.
- Cases exist where patients are treated for bipolar mania but later diagnosed with thyroid disorders.
- Thyroid conditions have been reported in bipolar patients during or after lithium treatment.
Purpose of the Study:
- To present a case of bipolar disorder with comorbid hyperthyroidism and mania following lithium discontinuation.
- To highlight the importance of considering thyroid dysfunction in specific patient populations.
Main Methods:
- Case review of a patient with a history of bipolar disorder.
- Analysis of clinical presentation including manic symptoms and hyperthyroidism.
- Examination of treatment response after lithium discontinuation.
Main Results:
- The patient presented with bipolar mania and hyperthyroidism concurrently.
- The condition emerged after the recent cessation of lithium treatment.
- This case underscores the complex interplay between thyroid status and mood disorders.
Conclusions:
- Consider comorbid hyperthyroidism in bipolar manic patients with partial response to standard mood stabilizers and antipsychotics.
- Routine thyroid screening may be beneficial in select bipolar disorder patients.
- Early identification and management of thyroid dysfunction are essential for effective psychiatric treatment.
Related Concept Videos
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...